Trial site
Kurashiki
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Sjögren's disease3 trials
- Chronic myeloid leukaemia2 trials
- Acute lymphoblastic leukaemia1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026